• Nie Znaleziono Wyników

Nuclear microscope

N/A
N/A
Protected

Academic year: 2021

Share "Nuclear microscope"

Copied!
6
0
0

Pełen tekst

(1)

fo

c

u

s

Foto's: Sam Rentmeester/Fmax

(2)

Nuclear microscope

Professor Freek Beekman and his team have developed a device that shows with

unprecedented accuracy precisely where biological or pharmaceutical substances are active

in a living animal. The U-Spect, more than ten of which have already been sold worldwide,

can dramatically reduce the use of animals in research.

Jos Wassink

The nuclear chemist proceeds with caution. His hands

in the fume cupboard are hidden behind a wall of lead

bricks. He observes his work through a thick plate of

yellow-tinted stained glass. Everything here in the nuclear

medicine research group is focused on radiation shielding.

Using a mixing tube, the analyst combines miniscule

quantities of antibody (as the key functional proteins) with

a solution of radioactive indium. By a chemical reaction,

the volatile metal atoms attach themselves to the protein

molecules, after which the mixture is labelled and ready

for use.

Here at the Radboud University Nijmegen Medical

Centre (UMC St. Radboud), mice are used in breast cancer

research. A mouse with a tumour under the skin is given

a tiny injection of the radioactive-labelled antibodies.

The animal is then placed under general anaesthetic in

the U-Spect, a device developed by TU Delft professor of

radiation detection and medical imaging, Professor Freek

Beekman. After a time, you are able to see exactly where

the antibodies are binding to tumour cells, as the camera

reveals where the radioactivity has accumulated.

“The goal of this research is personalised medicine,” says

Dr Peter Laverman, researcher in nuclear medicine. The

treatment of patients with antibody therapy costs tens

of thousands of euros and is not guaranteed to work for

everyone. It would, therefore, be very useful if we were able

to determine in advance whether the antibodies will bind

to the tumour. If they do not, there is very little point in

administering antibody therapy. It would also be useful

if we were able to determine the effect of the therapy by

using a Spect scanner to see if the tumour is shrinking or

disappearing (see text box: Visible radioactivity).

U-Spect is a Spect scanner specially designed for small

animals. U-Spect makes radioactive-labelled molecules

within the animal visible with the use of gamma rays

emitted by the unstable nuclei in radioactive decay. The

technique is universally applicable and only requires

suitable biological molecules (‘tracers’) to carry the

radioactivity to the appropriate organs. The passage of

drugs through the body, flushing out cocaine from the

brain, the growth of insulin-producing cells – this can all

be captured in images with a resolution of 0.35 millimetres

and to dynamic effect. In other words, allowing us

the same visual quality as a short film. “Scans would

only be used to measure developments in time,” says

Laverman. “We could save dozens of animals this way by

no longer having to kill a group of five mice for the sake

of research every five minutes, hour, two hours and four

hours.” Animals are currently still used and dissected for

determining the exact dose absorbed in different organs, a

process known as biodistribution. Further development

of the U-Spect should, however, enable us to detect even

these values from camera images.

Hobby

Professor Beekman of Applied Sciences admits he was

a bit of a late bloomer. Growing up as a teenager in the

1970s in Twente, in the east of Holland, he was a huge

fan of motorcross and the local rock group sensation,

Normaal. “You didn’t have to study to have fun,” the

spirit of those halcyon days still resonating in his voice.

Studying physics came later, while working as a technician

in a chip manufacturing plant for Philips in Nijmegen.

He was 26 at the time and started studying “as a hobby”.

At the same time, he was offered a part-time job in the

department of nuclear medicine at what was then the St.

Radboud Teaching Hospital in Nijmegen. He was initially

employed to take care of computer problems and oversee

quality control. However, conversations with the lung

specialist with whom he shared a room led to a growing

interest in the technology behind gamma cameras and the

reconstruction process – the complicated calculations used

to reconstruct the spatial distribution of radioactivity from

different images. In 1992, the Netherlands Organisation

for Scientific Research (NWO) awarded Beekman a grant

to develop an image reconstruction of a rotating gamma

Peter Laverman: "We could have dozens of

animals this way."

1•3 Delft Outlook

7

fo

c

u

s

‘The goal of this research is

personalised medicine’

(3)

fo

c

u

s

The vector prototype combines three techniques: PET Spect en CT.

been that some of the high-energy PET radiation would

fly through the collimator, creating blurry imaging. To

solve this problem, the group developed a collimator

with a greater wall thickness and four smaller channels

for each pinhole. This cluster collimator allowed us to

create PET images with a resolution of 0.7 millimetres.

“I’ve reached my first milestone at TU Delft. And it feels

good!” says Beekman. The PET and Spect devices have

been combined in a machine called the Vector (Versatile

Emission Computer Tomography), which is also able to

provide CT (computed tomography for 3D X-ray images).

The next stage is to build a 'dark room' for integrating

bioluminescence. “It will be the first scanner to depict

virtually the entire electromagnetic spectrum," says

Beekman. "This will allow us to detect dozens of processes

simultaneously.”

With his new machine, Beekman has become the David

of molecular imaging, pitting his strength against the

Goliath of Bioscan, a company with an extensive market

history and – according to their claims – ten times more

devices under their belt than anyone else. Beekman is

not allowing this comparison to intimidate him: “Just

last week our technicians were installing devices in both

America and China at the same time.”

camera. It is somewhat unorthodox for a student to

write his own research proposal, but Beekman saw no

alternative: “Nobody wanted to hire a 30-year-old PhD

student.” Professor Max Viergever from Utrecht University

was, however, interested in supervising him. Beekman

developed a computational technique that he claims works

a thousand times faster and ten times better than anything

previously in existence. In 2003, Beekman received a Vidi

grant to develop the U-Spect at Utrecht University –

a Spect device for small animals with a multi-pinhole

collimator and three fixed detectors.

In 2008, Beekman moved to TU Delft: an environment

that he believes was conducive to enabling his group to

be one of the few in the world to design systems from A to

Z in-house. This recently led to a remarkable expansion

in the U-Spect’s capacity: the device can now also yield

PET images (see text box). The problem until recently had

‘It will be the first scanner to

depict virtually the entire

electromagnetic spectrum’

(4)

9

fo

c

u

s

Visible radioactivity

A gamma camera makes high-energy electromag-netic radiation (gamma rays) emitted by radioactive decay visible through a special crystal, which emits light when a gamma photon is taken. The camera captures the position of the light pulses. The device has been in use in hospitals since the 1980s for the medical imaging of radioactive-labelled tumours, amongst other things. An iron plate full of holes (the collimator) works as a primitive lens by only imaging perpendicular incident radiation. This gives a projec-tion of the distribuprojec-tion of radioactivity. A spatial image, or an arbitrary cross-section, can be made by rotating the camera around the patient and filming the distribution from all angles, or by using multiple cameras positioned around the patient. A computer then reconstructs the images from the different spatial distribution. This technique is known as Spect (Single Photon Emission Tomography) and is used, for example, in myocardial perfusion imaging. With a resolution of 1 cm, the images are not particularly sharp.

PET

PET (Positron Emission Tomography) also produces spatial images using the gamma camera but does not require a collimator due to the properties of the positron – a particle which collides with an electron in the body and merges into two high-energy photons, which are emitted in opposite directions. Electronics in the camera, therefore, only count two simultaneous pulses at opposite positions. The line between these two positions gives the approximate location of the radioisotope. PET is widely used for locating tumours, which are distinguished from other tissues by their high consumption of glucose. When using PET imaging, glucose is labelled with Fluorine-18, an isotope that emits positrons as it decays. This makes the accumulation of glucose within a tumour visible to the gamma cameras.

U-spect

U-Spect is an ‘ultra-precise’ form of Spect for use with small animals. The technique uses a sophis-ticated collimator in the form of a cylinder with five rows of 15 very narrow channels ("pinholes") surrounded by three planar gamma detectors (see infographic). The device can display images of up 0.35 millimetres. Beekman began developing his

nuclear microscope in 2003 at Utrecht University with the aid of a Vidi grant. His product is aimed at research laboratories and is being launched through his company MILabs (Molecular Imaging Laboratories).

Further information: Professor Freek Beekman F.J.Beekman@tudelft.nl www.milabs.com

Combination of CT and Spect imaging shows the location of a subcutaneous tumour (orange/purple) in a mouse. The green trace is the remaining unbound antibody in the vicinity of the heart and kidneys. This is a frame from a 3-D film made by Wim Bleeker, Genmab BV, in collaboration with the University Medical Centre (UMC) Utrecht.

Injected technetium-99m detects bones in a mouse torso. Mouse looking right. The above image is a combination of Spect and CT with the individual components below. The photo gives a good impression of the high-resolution of the Spect image.

Photo:

MILabs

Photo:

MILabs

(5)

Radioactive labels

Tracers (which bind to tumour cells or heart tissue, for example) are linked to a radioactive isotope. They are given a radioactive 'label', as it were, that is detectable within the body.

The efficacy of new drugs is tested using mice. For example, the mechanism by which medications bind to tumour cells while ignoring healthy tissue. In order to study this linkage, tumour cells are injected into mice. These animals are later injected with radio-labelled antibodies, which bind to the tumour. An isotope scan will then show whether the antibodies have actually concentrated at the tumour's location (which is known).

Collimatorplaat

The radioactive isotope inside the body emits radiation in all directions, so this will intersect with a large area of the detector [2]. This makes it impossible to localise the source of the radiation. For this reason, a collimator (a perforated lead plate) [3] is placed just in front of the detector crystal. Only radiation travelling on a path perpen-dicular to the surface of this plate can pass through the apertures. A flash of light in the crystal can only be generated by a radioactive source in the patient perpendicularly below that spot in the detector. A single detector cannot measure the depth of the gamma source in the body.

Injecting a radioactive label

The patient (or a mouse) is injected with a small amount of radioactive substance (or this is administered with the food). The substance disperses throughout the body. A scan can be made about one hour later.

Detecting radiation

Radioactive substances decay, emitting ionising radiation in the process. This radiation can be measured using special scanning devices, known as isotope scanners. The radiation reveals where the radioactive labels, hence also the tracers, are concentrated in the body. Cells (for example) at these sites in tissues or organs are taking up more nutrients from the blood than normal healthy cells. This may indicate the presence of tumour cells. Isotope scans can reveal metastases that are not visible on a traditional CT scan.

Gamma detector

A gamma detector consists of a large crystal that emits light when it is hit by gamma rays. An array of photo-detectors at the back records the location of each flash of light in the crystal.

Three-dimensional radiation image

If gamma detectors are placed around the patient (or rotated), a computer can construct a three-dimensional image of the radioactive substance's distribution throughout the body.

Measuring U-Spect: Animal

A mouse is first injected with a radioactive substance and then anesthetised. The animal is laid on a heated bed in a container, which is then inserted into the scan ner using a mechanical arm.

Measuring U-spect:

Collimator acts like a magnifier

In order to increase measurement certainty, the flat collimator plate is replaced by a cylindrical collimator with holes in the sides. Only radiation emitted from a specific area can pass through these 'pinholes' [7] . Each hole functions as a 'camera obscura', projecting the radiation onto one of three fixed detectors with a measurement uncertainty of 3.5 mm. The magnification factor (about 10) is deter-mined by the ratio of the distances between the animal, the wall of the collimator, and the detector. In this way, the resolution of the U-Spect has improved from 3.5 mm [8] to 0.35 mm [9]. If the position of the mouse is changed relative to the collimator, the radiation in a larger measurement area can be determined.

Measuring U-Spect: Measurement area

The attendant uses three cameras to determine which part of the animal is to be scanned. Each measurement focuses on a cylindrical space measuring 12 mm (diameter) by 8 mm.

Measuring U-Spect: CT-scan

The U-Spect has a built-in CT scanner (a rotating X-ray tube that produces 3D X-ray images), to create a 3D anatomical image showing the location of the radiation.

Spect (Single Photon Emission Computerised Tomography) scanners are designed to measure a single gamma photon. Isotopes that are suitable for use in Spect (e.g. technetium or iodine) decay with the emission of a single photon. Spect isotopes have half-lives ranging from a few hours to several days. This technique has a measurement uncertainty of approximately 10 mm.

Tumours

Scanner used to examine patients SPECT-SCANNER SPECT U-SPECT

Spect scan images have an uncertainty of about 10 mm. While this uncertainty permits effective scans to be made of humans, it is too large for studies of tumours in the brains or livers of mice. U-Spect was developed to produce pin-sharp scans of even very small animals.

Special scanner for small animals U-SPECT a b d Collimator tube Pin-hole Gamma detector X-ray tube 20 cm 2 cm Measurement uncertainty of detector 3,5 mm Uncertainty measurement 0,35 mm Gamma radiation Without a collimator Collimator plate Radioactive label Tracers c

(6)

Radioactive labels

Tracers (which bind to tumour cells or heart tissue, for example) are linked to a radioactive isotope. They are given a radioactive 'label', as it were, that is detectable within the body.

The efficacy of new drugs is tested using mice. For example, the mechanism by which medications bind to tumour cells while ignoring healthy tissue. In order to study this linkage, tumour cells are injected into mice. These animals are later injected with radio-labelled antibodies, which bind to the tumour. An isotope scan will then show whether the antibodies have actually concentrated at the tumour's location (which is known).

Collimatorplaat

The radioactive isotope inside the body emits radiation in all directions, so this will intersect with a large area of the detector [2]. This makes it impossible to localise the source of the radiation. For this reason, a collimator (a perforated lead plate) [3] is placed just in front of the detector crystal. Only radiation travelling on a path perpen-dicular to the surface of this plate can pass through the apertures. A flash of light in the crystal can only be generated by a radioactive source in the patient perpendicularly below that spot in the detector. A single detector cannot measure the depth of the gamma source in the body.

Injecting a radioactive label

The patient (or a mouse) is injected with a small amount of radioactive substance (or this is administered with the food). The substance disperses throughout the body. A scan can be made about one hour later.

Detecting radiation

Radioactive substances decay, emitting ionising radiation in the process. This radiation can be measured using special scanning devices, known as isotope scanners. The radiation reveals where the radioactive labels, hence also the tracers, are concentrated in the body. Cells (for example) at these sites in tissues or organs are taking up more nutrients from the blood than normal healthy cells. This may indicate the presence of tumour cells. Isotope scans can reveal metastases that are not visible on a traditional CT scan.

Gamma detector

A gamma detector consists of a large crystal that emits light when it is hit by gamma rays. An array of photo-detectors at the back records the location of each flash of light in the crystal.

Three-dimensional radiation image

If gamma detectors are placed around the patient (or rotated), a computer can construct a three-dimensional image of the radioactive substance's distribution throughout the body.

Measuring U-Spect: Animal

A mouse is first injected with a radioactive substance and then anesthetised. The animal is laid on a heated bed in a container, which is then inserted into the scan ner using a mechanical arm.

Measuring U-spect:

Collimator acts like a magnifier

In order to increase measurement certainty, the flat collimator plate is replaced by a cylindrical collimator with holes in the sides. Only radiation emitted from a specific area can pass through these 'pinholes' [7] . Each hole functions as a 'camera obscura', projecting the radiation onto one of three fixed detectors with a measurement uncertainty of 3.5 mm. The magnification factor (about 10) is deter-mined by the ratio of the distances between the animal, the wall of the collimator, and the detector. In this way, the resolution of the U-Spect has improved from 3.5 mm [8] to 0.35 mm [9]. If the position of the mouse is changed relative to the collimator, the radiation in a larger measurement area can be determined.

Measuring U-Spect: Measurement area

The attendant uses three cameras to determine which part of the animal is to be scanned. Each measurement focuses on a cylindrical space measuring 12 mm (diameter) by 8 mm.

Measuring U-Spect: CT-scan

The U-Spect has a built-in CT scanner (a rotating X-ray tube that produces 3D X-ray images), to create a 3D anatomical image showing the location of the radiation.

Spect (Single Photon Emission Computerised Tomography) scanners are designed to measure a single gamma photon. Isotopes that are suitable for use in Spect (e.g. technetium or iodine) decay with the emission of a single photon. Spect isotopes have half-lives ranging from a few hours to several days. This technique has a measurement uncertainty of approximately 10 mm.

Tumours

Scanner used to examine patients SPECT-SCANNER SPECT U-SPECT

Spect scan images have an uncertainty of about 10 mm. While this uncertainty permits effective scans to be made of humans, it is too large for studies of tumours in the brains or livers of mice. U-Spect was developed to produce pin-sharp scans of even very small animals.

Special scanner for small animals U-SPECT a b d Collimator tube Pin-hole Gamma detector X-ray tube 20 cm 2 cm Measurement uncertainty of detector 3,5 mm Uncertainty measurement 0,35 mm Gamma radiation Without a collimator Collimator plate Radioactive label Tracers c Radioac tieve lab els Zoekst offen (die zich bijv oorbeeld binden aan

tumor-cellen of har tw

eefsel) w orden gekoppeld met een

radioac tieve isot

oop. Z e krijgen als het w are een r

adio-actief 'label' da t detec

teer baar is in het lichaam.

De w erking v an nieuwe geneesmiddelen wor dt getest op muiz en. Bijvoor beeld het mechanisme dat er v oor moet zor

gen dat medicijnen zich binden aan tumorcellen

maar gezond w eefsel neger en. Om deze koppeling te bestuder en krijgen muiz en tumorcellen ingebracht. Vervolgens

wor den (bijv.) r

adioactief gelabelde

antilichamen ingespot en die zich moeten

hechten aan de tumor . Een isot

openscan

laat zien of de an tilichamen zich

daad-wer kelijk conc entr eren op de (bekende) lokatie v an de tumor. Collima torplaa t Omdat de r adioactiev e iosotoop in het

lichaam in alle rich tingen straling uitz

endt, zou een g root deel v an de detec tor w orden getroff en . De br on van de str aling blijft dan onduidelijk. V lak voor het det ectiek

ristal

bevindt zich daarom een loden c ollimator

, een

plaat lood met gaa tjes , die alleen

lood-rech t invallende str aling doorlaa t. E en lichtflits in het kristal k an alleen afkomstig zijn van een

radioac tieve br on in de patiën t loodrech t onder de getroff en plaats op de det ector . Met één detec tor w ordt de diept e van de

gamma-bron in het lichaam niet gemet en. Inspuit en radioac tieve det ectiest of De pa tiënt (of een muis) k rijgt een k leine hoeveelheid r adioactiev e stof ingespot en

(of toegediend via v oedsel). De st

of

verspr eidt zich door het lichaam. Na circa

een uur kan een scan w orden gemaakt . Str aling detec ter en Radioac tieve st offen v allen uiteen en z enden daarbij r adioactiev e straling uit . Speciale scan-apparatuur , isotopenscanners , kunnen deze str aling meten. D e straling geef t aan waar de r adioactiev e labels, en dus de zoekst offen, zich c oncen trer en in het lichaam. Op deze plaa tsen - in weef sels of organen -

nemen de cellen (bijv .) meer voedingsst

offen

uit het bloed op dan gewone gez onde

lichaamscellen. Dit k an een indicatie zijn v

oor

de aanw ezigheid van tumor

cellen. M et

isotopenscans k unnen uitzaaiingen wor

den

aangetoond die bij een tr aditionele CT-scan

niet zichtbaar zijn. Gammadet

ector

Een gammadet ector bestaa

t

uit een groot k ristal da t licht

uitzendt als het door gamma-straling w ordt getr offen. E en matr ix van f otodet ector en achter het k ristal legt de plaa ts

van elke lich tflitsje in het kristal

vast . Driedimensionaal stralingsb eeld Door gammadet ector en rondom de pa tiënt t e plaatsen (of rond t e laten dr aaien), kan een comput er een

driedimen-sionaal beeld construer en van de radioac tieve st of in het lichaam. Meting U-S pect: Dier De muis k rijgt r adioactiev e stof ingespoten en w ordt onder narcose gebr acht. Het dier w

ordt

op een ver war md bedje in een

houder gelegd die op een

arm de scanner in schuift. Meting U-Spect: Collima tor w erkt als v ergr oter Om een grot ere meetnauwkeur igheid te r e-aliseren is de pla tte c ollimator plaat v

ervan-gen door een cilindervor mige collima

tor

met gaatjes in de buisw and. D

eze gaa tjes, of

'pinholes' , laten alleen str aling door die

vanuit één specifiek gebied w orden uit

ge-zonden. Elk gaa tje wer

kt hierbij als een

'camer a obscura' die de str

aling op eén van

de dr ie vast e detec tor en projec teer t met een meetonnauwkeurigheid van 3,5 mm. D e ver

-houding tussen de afstanden tussen dier, collima tor wand en de det ector bepaalt de ver grotingsfac tor (cir ca 10). Op deze manier

is het scheidend ver mogen van de U-S

pect ver kleind v an 3,5 mm naar 0,35 mm . Door de positie v an de muis t.o .v. de c olli-mator t e ver anderen, k an de straling in een grot er meetgebied w orden bepaald . Meting U-S pect: M eetgebied De oper ator bepaalt met behulp v an

drie camer a's w

elk deel van het dier gescand moet wor den. Per

meting wor dt een cilinder van 12 mm

(diameter) bij 8 mm door gemeten. Meting U-S pect: C T-sc an De U-S pect heef t een ingebouwde C

T-scanner (een draaiende r öntgenbuis maakt 3D rön tgenbeelden) z odat de lo catie v an de radioac tieve str

aling in een 3D-ana tomisch beeld kan w orden get oond. Een S pect-scanner (Single Phot on Emission Tomog raph y) rich t zich op het meten v

an een enkel gammafot on.

Iso-topen geschikt v oor Spect

(bijv. T echnetium of Jodium)

zenden bij hun v erval een

enkel fot on uit. S pect-isot

o-pen hebben halfwaar detijden van enige ur en tot dagen. D e meetonnauwkeur igheid van deze t echniek is circa 10 mm.

Tumor

en

Scanner v oor patiën tenonder zoek SP EC T-S CA NN ER SP EC T U-S PE CT De onz ekerheid v

an het beeld van een S

pect-scan is circa 10 mm. D eze onnauwkeur

igheid is

voldoende v oor een scan van een mens

, maar is

niet voldoende om tumor en in de hersenen of

lever v an een muis te bestuder

en. Om ook bij

kleine dieren scher pe scans te k unnen maken, is de U-Spect ontwik keld. Scanner sp eciaal voor kleine dieren U-S PE CT a b c d Collima tor-buis Pin-hole Gamma-detec tor Röntgen-buis 20 cm 2 cm Meet onnauw-keurigheid detec tor 3,5 mm Onnauw -keurigheid meting 0,35 mm Gamma-straling Zonder collima tor Collima tor-plaat Radioac tief label Zoek -stoff en 1•3 Delft Outlook illustration & text:

Cytaty

Powiązane dokumenty

Wskazani uczniowi, gdy wykonają zadania, muszą niezwłocznie przesłać wyniki przez komunikator na e-dzienniku, lub mailem na adres:!. matematyka2LOpm@gmail.com skan

• obliczad pole powierzchni sześcianu, znając jego objętośd 6/237..

We performed data analysis of the SGD observation, SGD background estimation, and SGD Monte Carlo simulations, and successfully detected polarized gamma-ray emission from the

Tata Maćka przepłynął na basenie 940 m, Maciek o 620 m mniej

Rygle z rur okr¹g³ych do d³ugoœci 1,50 m, mog¹ zostaæ z powodzeniem zastosowane jako rygle podporowe dla podestów z zaczepami podporowymi, lub dla podestów z poza systemu.

The new collimator for the 24-module barrel tomograph will take ad- vantage of the symmetry of the detector and thus, it consists of two lead cylinders connected with screws (size

How- ever, depending on the jet momentum, on average between 35 % and 90 % of the energy in jets is carried by particles that are not measured in situ using the isolated track

Bardzo często (por. Ciołkosz, Bielecka, 2005; Ciołkosz, Poławski, 2006; Pietrzak 2010) użytkowanie ziemi jest traktowane jako nadrzędne w stosunku do pokrycia terenu.. Pokrycie